BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32058212)

  • 21. MicroRNA-214 Suppresses Ovarian Cancer by Targeting β-Catenin.
    Liu Y; Lin J; Zhai S; Sun C; Xu C; Zhou H; Liu H
    Cell Physiol Biochem; 2018; 45(4):1654-1662. PubMed ID: 29486472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. circ_100984-miR-432-3p axis regulated c-Jun/YBX-1/β-catenin feedback loop promotes bladder cancer progression.
    Tong L; Yang H; Xiong W; Tang G; Zu X; Qi L
    Cancer Sci; 2021 Apr; 112(4):1429-1442. PubMed ID: 33314480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-221 Promotes Epithelial-Mesenchymal Transition through Targeting PTEN and Forms a Positive Feedback Loop with β-catenin/c-Jun Signaling Pathway in Extra-Hepatic Cholangiocarcinoma.
    Li J; Yao L; Li G; Ma D; Sun C; Gao S; Zhang P; Gao F
    PLoS One; 2015; 10(10):e0141168. PubMed ID: 26501139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway.
    Chi Y; Wang F; Zhang T; Xu H; Zhang Y; Shan Z; Wu S; Fan Q; Sun Y
    J Cell Mol Med; 2019 Sep; 23(9):6295-6307. PubMed ID: 31273950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
    Zhuang XH; Liu Y; Li JL
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β-catenin downregulates Dicer to promote ovarian cancer metastasis.
    To SKY; Mak ASC; Eva Fung YM; Che CM; Li SS; Deng W; Ru B; Zhang J; Wong AST
    Oncogene; 2017 Oct; 36(43):5927-5938. PubMed ID: 28650464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling.
    Lin Y; Chen X; Lin L; Xu B; Zhu X; Lin X
    Cell Mol Biol Lett; 2024 May; 29(1):63. PubMed ID: 38698330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
    Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
    Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-590-3p Targets Cyclin G2 and FOXO3 to Promote Ovarian Cancer Cell Proliferation, Invasion, and Spheroid Formation.
    Salem M; Shan Y; Bernaudo S; Peng C
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.
    Tan Z; Zheng H; Liu X; Zhang W; Zhu J; Wu G; Cao L; Song J; Wu S; Song L; Li J
    Oncotarget; 2016 Apr; 7(17):24076-87. PubMed ID: 26992223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
    Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
    Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
    Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
    Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TSN inhibits cell proliferation, migration, invasion, and EMT through regulating miR-874/HMGB2/β-catenin pathway in gastric cancer.
    Yuan F; Zhao ZT; Jia B; Wang YP; Lei W
    Neoplasma; 2020 Sep; 67(5):1012-1021. PubMed ID: 32484696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-543 Inhibits the Migration and Epithelial-To-Mesenchymal Transition of TGF-β-Treated Endometrial Stromal Cells via the MAPK and Wnt/β-Catenin Signaling Pathways.
    Wang L; Liu D; Wei J; Yuan L; Zhao S; Huang Y; Ma J; Yang Z
    Pathol Oncol Res; 2021; 27():1609761. PubMed ID: 34257616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-5590-3p inhibits the proliferation and invasion of ovarian cancer cells through mediating the Wnt/β-catenin signaling pathway by targeting TNIK.
    Wu X; Zhong Y; Zhang H; Li M
    Histol Histopathol; 2024 Mar; 39(3):345-355. PubMed ID: 37318197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PCNP promotes ovarian cancer progression by accelerating β-catenin nuclear accumulation and triggering EMT transition.
    Dong P; Fu H; Chen L; Zhang S; Zhang X; Li H; Wu D; Ji X
    J Cell Mol Med; 2020 Jul; 24(14):8221-8235. PubMed ID: 32548978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop.
    Li T; Jian X; He H; Lai Q; Li X; Deng D; Liu T; Zhu J; Jiao H; Ye Y; Wang S; Yang M; Zheng L; Zhou W; Ding Y
    J Exp Clin Cancer Res; 2018 Sep; 37(1):238. PubMed ID: 30253791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
    Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
    Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.